Tumor blood vessels
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Growth of tumors usually depends on the development of the tumor’s own vasculature. Small avascular tumors (1–2 mm3) cannot continue growth provided an equilibrium between pro-angiogenic and anti-angiogenic factors is maintained within the tumor environment. Angiogenesis is not the only factor responsible for tumor blood vessels forming, as vasculogenic mimicry plays an equally substantial role in this process. Vessel-like structures formed during this process are made up from cancer cells, macrophages and mast cells. Certain neoplasms are capable of growing without developing their own vasculature; instead they secure growth via normal blood vessels of the host. Slowed-down blood flow through an abnormally built tumor vascular network is the main reason for cancer cells’ underoxygenation (hypoxia). Defective blood vessels, with hypoxia resulting, play a major role in tumor progression. Underoxygenation induces formation of novel vessels and these new defective vessels are in turn the principal reason for hypoxia. The latter increases cancer cells’ malignancy and invasiveness. A particular process, called transdifferentiation, takes place in tumor vasculature when hypoxia is present and involves neoplastic cells transforming into endothelial cells. Since growth of a tumor is dependent on its own blood supply, inhibition of such vascular network growth and/or damage to this network should exert a strong impact on tumor growth. Long-term administration of anti-angiogenic drugs, however, encounters unexpected problems. Anti-angiogenic drug resistance, together with paradoxical stimulation of invasiveness and metastasis by these drugs, has lately become a dominant issue in anticancer therapy.
Authors and Affiliations
Stanisław Szala, Magdalena Jarosz
Keywords
Related Articles
- EP ID EP66505
- DOI -
- Views 142
- Downloads 0
Novel PKD1 mutations – the effect on clinical phenotype of ADPKD patients in Lower Silesia
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development and progressive enlargement of cysts in the kidneys. The diagnosis of ADPKD is usually determined by criteria of rena...
Hair follicle as a novel source of stem cells
Tissue engineering as a rapidly developing branch of science offers hope for the use of its products in medical practice. Among the components of tissue substitutes are different types of cells, especially stem cells. A...
Indywidualizacja terapii przeciwnowotworowej; molekularne uwarunkowania mechanizmów działania nowoczesnych leków onkologicznych
Dysregulacja procesu transmisji sygnału na poziomie komórkowym, wynikająca z genetycznych nieprawidłowości, jest istotnym czynnikiem inicjacji, promocji i progresji nowotworów. Możliwość kontrolowania aktywności odpowied...
Sea-buckthorn (Hippophae rhamnoides L.) as a source of compounds with antitumor and radioprotective activity
This work presented characteristics of sea buckthorn (H. rhamnoides), the bioactive compounds they contain and their pro-health, anti-cancer and radioprotective activity. Studies have shown that antioxidants contained in...
Zakażenia adenowirusami u pacjentów z zaburzeniami odporności
Ludzkie adenowirusy, należące do rodziny Adenoviridae, zostały zaklasyfikowane do siedmiu gatunków, liczących razem 56 podtypów. Adenowirusy są szeroko rozpowszechnione w populacji ludzkiej, przy czym rzadko są związane...